OCT-based DAPT Cessation in HBR Patients

Clinical trial NCT07238764 · COMPLETED

Trial details

NCT number: NCT07238764
Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

High Bleeding Risk Patients DAPT(Dual Antiplatelet Therapy)Coronary Artery Disease Diabetes Mellitus

Start date: 2022-06-12
Primary completion: 2025-05-09
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.